Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Void · Coders disagree

Rules 1.1.0 · as of 14 Sep 2026

Quote

“To put my dime down, I don't think MDMA-AT will be approved by the FDA when it meets to discuss the 10-1 and 9-2 against AdComm votes cautioning against approval of the combination product at this time.”
· Saving MDMA VII: This isn't The First Drug to Have Problems Getting Approved · substack post Paid

The author's headline call in the seventh 'Saving MDMA' article: the FDA will not approve Lykos Therapeutics' NDA for MDMA-assisted therapy at the pending decision, following the June 2024 AdComm votes of 10-1 and 9-2 against. Post dated 2024-06-26, before the FDA action date.